Fun Insights from my Portfolio
Deepak Nitrite generates more Cash from Operations than Laurus Labs.
Deepak Nitrite: 999cr
Laurus Labs: 733cr
Deepak grew its CFO by ~30% YoY while Laurus grew its CFO by more than~100% YoY
More from Tar ⚡
OPM: 23%
Free Float: <5%
QoQ continuous increase in ownership by institutions
ROE: ~20%
ROCE: ~28%
EV by EBITDA: 15
Leading developer of Indigenous Military Drones
Exports are prime focus for the company
D: Invested, not a recommendation
Lots of under owned stocks with robust financials within Defense Sector \U0001fa96\U0001f396\ufe0f
— Tar \u26a1 (@itsTarH) April 12, 2022
You don't even have to try looking very hard to find something interesting
Please do your due diligence and do not copy me blindly here
My investments in IEX are part of an experiment to hold a good stock for 10 yrs + buying sporadically
IEX has also started ground work for trading carbon credits
Still believe this is one stock where dividend every year in 10 years can be equal to my entire investment amount considering it throws up so much cash
Still maintain
NSE + Zerodha =
#IEX in my PF is a giant growing dividend paying Gorilla
— Tar \u26a1 (@itsTarH) October 18, 2021
Main reason I don't mess around with my holdings is cause I expect it to.
Pay Dividend = to my investment within the next decade
Glad they are considering Bonus Issue (tax favorable) instead of Cash Dividend. pic.twitter.com/2cLt6yK0Xw
More from Uvlearnings
In an example of how deeply ingrained misogyny is in the Indian system, billionaire investor Rakesh Jhunjhunwala asked the management of Jubilant Pharmova: \u201cHow can we be lower than the lady? We have to beat her,\u201d in a slighting reference to @kiranshaw.
— Dr. Kailashnath Koppikar (@koppik) June 26, 2021
https://t.co/1dkZ9JMLLr
@unseenvalue Given high capex/opex cost structures of US/Japan/EU, how will they be able to compete with Indian API companies? https://t.co/OYhC2PUZpL
— Hiren (@hiren_investing) August 11, 2021